141 related articles for article (PubMed ID: 25586431)
1. [Therapy of metastatic colorectal carcinoma exemplified in metachronous liver metastases].
Siebenhüner A; Winder T; Petrowsky H; Clavien PA; Pestalozzi B
Praxis (Bern 1994); 2015 Jan; 104(2):67-79. PubMed ID: 25586431
[No Abstract] [Full Text] [Related]
2. Colorectal cancer: metastatic patterns and prognosis.
Patanaphan V; Salazar OM
South Med J; 1993 Jan; 86(1):38-41. PubMed ID: 8420014
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of colorectal liver metastases].
Folprecht G
Dtsch Med Wochenschr; 2013 Oct; 138(41):2098-103. PubMed ID: 24085366
[TBL] [Abstract][Full Text] [Related]
4. [Multimodal treatment of colorectal liver metastases].
Albertsmeier M; Stintzing S; Guba M; Werner J; Angele M
MMW Fortschr Med; 2015 Aug; 157(14):47-9. PubMed ID: 26289886
[No Abstract] [Full Text] [Related]
5. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
[TBL] [Abstract][Full Text] [Related]
6. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.
Ammori JB; Kemeny NE; Fong Y; Cercek A; Dematteo RP; Allen PJ; Kingham TP; Gonen M; Paty PB; Jarnagin WR; D'Angelica MI
Ann Surg Oncol; 2013 Sep; 20(9):2901-7. PubMed ID: 23771246
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
8. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
[TBL] [Abstract][Full Text] [Related]
9. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
[TBL] [Abstract][Full Text] [Related]
10. The rise and fall of a longed for clinical trial in patients with generalized colorectal cancer.
Arbman G; Påhlman L; Glimelius B
Acta Oncol; 2013 Nov; 52(8):1779-82. PubMed ID: 23826848
[No Abstract] [Full Text] [Related]
11. Current treatment of colorectal liver metastases.
Tsalis K; Vasiliadis K; Christoforidis E; Vergos O; Angelopoulos S; Botsios D; Betsis D
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s174-6. PubMed ID: 15655613
[TBL] [Abstract][Full Text] [Related]
12. High-dose FOLFIRI, surgery, and radiofrequency ablation for patients with unresectable liver metastases from colorectal cancer.
Hebbar M; Truant S; Desauw C; Sergent-Baudson G; Cattan S; Piessen G; Pruvot FR
Anticancer Res; 2013 Apr; 33(4):1603-7. PubMed ID: 23564804
[TBL] [Abstract][Full Text] [Related]
13. [Liver resections of metastases of non-colorectal primary tumors].
Seifert JK; Junginger T
Chirurg; 1996 Feb; 67(2):161-8. PubMed ID: 8881214
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes.
Viganò L; Langella S; Ferrero A; Russolillo N; Sperti E; Capussotti L
Ann Surg Oncol; 2013 Mar; 20(3):938-45. PubMed ID: 23010733
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of concomitant and recurrent pulmonary metastases after surgery for colorectal liver metastases.
Chua TC; Al-Alem I; Zhao J; Glenn D; Liauw W; Morris DL
Ann Surg Oncol; 2012 Jan; 19(1):75-81. PubMed ID: 21710327
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathological features of liver metastases from colorectal cancer in relation to prognosis.
Morino T; Tanaka J; Tobe T
Nihon Geka Hokan; 1991 May; 60(3):154-64. PubMed ID: 1776910
[TBL] [Abstract][Full Text] [Related]
17. Incomplete operative removal of colorectal liver metastases followed by chemotherapy decreases survival in comparison to chemotherapy alone.
Popov IP; Milicevic M; Kecmanovic D; Tomasevic Z; Radosevic-Jelic Lj; Borojevic N; Micev MT; Kezic I
J Exp Clin Cancer Res; 2006 Sep; 25(3):313-9. PubMed ID: 17167970
[TBL] [Abstract][Full Text] [Related]
18. Current management of colorectal liver metastases.
Martin LW; Warren RS
Surg Oncol Clin N Am; 2000 Oct; 9(4):853-76; discussion 877-8. PubMed ID: 11008255
[TBL] [Abstract][Full Text] [Related]
19. Synchronous and metachronous liver metastases in patients with colorectal cancer.
Okholm C; Mollerup TK; Schultz NA; Strandby RB; Achiam MP
Dan Med J; 2018 Dec; 65(12):. PubMed ID: 30511638
[TBL] [Abstract][Full Text] [Related]
20. Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer.
Khattak MA; Martin HL; Beeke C; Price T; Carruthers S; Kim S; Padbury R; Karapetis CS
Clin Colorectal Cancer; 2012 Dec; 11(4):247-54. PubMed ID: 22763194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]